retatrutide 12 mg Peptide: 12mg GLP-3RT (Retatrutide)12MG | Full Circle

It is not known if Wegovy will cause thyroid tumors or a type of thyroid cancer called medullary thyroid carcinoma (MTC) in people Do not use Wegovy if you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Do not use Wegovy if: you or any of your family have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC) or if you have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) you have had a serious allergic reaction to semaglutide or any of the ingredients in Wegovy injection or Wegovy tablets

During your consultation, Kristina reviews your medications, supplements, and lifestyle to flag anything that could interfere with the infusion

Divided doses: Splitting your daily dose into two servings may help maintain steady levels

Hypoglycemia risk: Patients taking GLP-1 agonists with insulin or sulfonylureas need close glucose monitoring, as dose adjustments of these medications may be necessary

References Bozkurt B, Ahmad T, Alexander K, et al